SYRS - Syros Pharmaceuticals Inc. (SYRS) CEO Nancy Simonian on Q1 2019 Results - Earnings Call Transcript
Syros Pharmaceuticals, Inc. (SYRS)
Q1 2019 Earnings Conference Call
May 01, 2019 8:30 AM ET
Company Participants
Naomi Aoki - Vice President of Corporate Communications & Investor Relations
Nancy Simonian - Chief Executive Officer
Joe Ferra - Chief Financial Officer
David Roth - Chief Medical Officer
Eric Olson - Chief Scientific Officer
Conference Call Participants
Phil Nadeau - Cowen & Company
Ted Tenthoff - Piper Jaffray
Jason Butler - JMP Securities
Anna Vorobyeva – ROTH Capital
Mark Breidenbach - Oppenheimer
Presentation
Operator
Good morning and welcome to Syros Pharmaceuticals First Quarter 2019 Financial Results Conference